期刊
EUROPEAN JOURNAL OF OPHTHALMOLOGY
卷 33, 期 5, 页码 NP47-NP50出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/11206721221126308
关键词
Cytomegalovirus; uveitis; belatacept; kidney transplant recipient
This case report describes a kidney transplant recipient who developed anterior and intermediate uveitis with CMV infection under belatacept therapy. CMV infection was confirmed using polymerase chain reaction assays. Belatacept therapy was interrupted and medication treatments were initiated, leading to successful control of inflammation.
Introduction: Belatacept is associated with a higher incidence of cytomegalovirus (CMV) disease and atypical presentations. Ocular manifestations are rare, representing up to 5% of disease manifestations and previous cases consisted in isolated retinitis. Case Description: Herein, we report the case of an 81-year-old kidney transplant recipient who developed an anterior and intermediate uveitis under belatacept therapy. The diagnosis was established using quantitative CMV polymerase chain reaction assays in the aqueous humor. Belatacept was interrupted and oral and topical valganciclovir treatments were instituted. Lesions however extended, leading to intensify the treatment by intra-venous and intra-vitreal ganciclovir injections. Visual acuity stabilized and ocular inflammation was finally controlled after 3 months. Conclusion: Clinicians should be aware of CMV infection as a cause of anterior uveitis under belatacept-based regimen, even in the absence of symptoms suggestive of systemic CMV replication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据